Skip to main content
The Maple Markets

Toronto Stock Exchange (TSX) · MDNA.TO · ISIN CA58490H1073

Medicenna Therapeutics Corp.

0.4250 CAD

+0.02(+4.94%)up

Previous close · Sep 18, 15:49 ET

Data last updated: (22 h ago)· Delayed exchange data

Sign in to add to portfolio

Medicenna Therapeutics Corp. (MDNA.TO) trades on the Toronto Stock Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 32.21M CAD. The company reports around 15 employees. Its ISIN is CA58490H1073. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

Toronto Stock Exchange (TSX)

ISIN

CA58490H1073

Sector

Healthcare

Industry

Biotechnology

Country

CA

Market cap

32.99M CAD

Employees

15

Previous close

0.41 CAD

Day range

0.41 – 0.43

52-week range

0.34 – 1.97

Volume

39.65K

50-day average

0.40 CAD

200-day average

0.66 CAD

Asset type

Equity

About Medicenna Therapeutics Corp.

Medicenna Therapeutics Corp. is an immunotherapy firm focused on creating and commercializing Superkines and "empowered Superkines" to combat cancer and various other illnesses. Their primary candidate, MDNA55, an interleukin-4 (IL-4) empowered cytokine, has successfully finished Phase IIb trials for recurrent glioblastoma and is also being investigated for other brain and non-brain tumor types in earlier developmental stages. The company's pipeline also includes MDNA11, an improved IL-2 variant designed to stimulate immune responses against cancer; MDNA209, an IL-2 antagonist aimed at autoimmune conditions like multiple sclerosis and graft-versus-host disease; MDNA413, a dual IL-4/IL-13 antagonist for use in cancer immunotherapy; and MDNA132, an IL-13 Superkine targeting solid tumors. Furthermore, Medicenna utilizes its BiSKITs platform to engineer bespoke Superkines by joining them with proteins, antibodies, cytokines, or other Superkines. The company's main office is located in Toronto, Canada.

Company website

Frequently asked

+
What is the MDNA.TO share price today?
This page shows the latest available Medicenna Therapeutics Corp. (MDNA.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.
+
Where is Medicenna Therapeutics Corp. listed?
Medicenna Therapeutics Corp. trades on the Toronto Stock Exchange under the symbol MDNA.TO, ISIN CA58490H1073.
+
How large is Medicenna Therapeutics Corp.?
Its market capitalisation is approximately 32.21M CAD, based on the latest available price and share count from our data provider.

All Medicenna Therapeutics Corp. data comes from exchange and provider feeds for the Toronto Stock Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.

We use necessary cookies to run the site and, only with your permission, analytics cookies to understand what readers use. Cookie policy